Evidence map›Paper›PMID 40895073›Full record

ArticleArXiv2025

FlowMol3: Flow Matching for 3D De Novo Small-Molecule Generation.

Ian Dunn, David R Koes

Abstract readPreprint
In one paragraph

Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Ian DunnDepartment of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.
David R KoesDepartment of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.

Funding

New Methods and Tools for Computational Drug Discovery: Diversity SupplementR35GM140753 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOES, DAVID RYAN · 2021 to 2025
$2.2M
NIGMS NIH HHS R35 GM140753
6 · The paper itself

Abstract

A generative model capable of sampling realistic molecules with desired properties could accelerate chemical discovery across a wide range of applications. Toward this goal, significant effort has focused on developing models that jointly sample molecular topology and 3D structure. We present FlowMol3, an open-source, multi-modal flow matching model that advances the state of the art for all-atom, small-molecule generation. Its substantial performance gains over previous FlowMol versions are achieved without changes to the graph neural network architecture or the underlying flow matching formulation. Instead, FlowMol3's improvements arise from three architecture-agnostic techniques that incur negligible computational cost: self-conditioning, fake atoms, and train-time geometry distortion. FlowMol3 achieves nearly 100% molecular validity for drug-like molecules with explicit hydrogens, more accurately reproduces the functional group composition and geometry of its training data, and does so with an order of magnitude fewer learnable parameters than comparable methods. We hypothesize that these techniques mitigate a general pathology affecting transport-based generative models, enabling detection and correction of distribution drift during inference. Our results highlight simple, transferable strategies for improving the stability and quality of diffusion- and flow-based molecular generative models.

Identifiers

PMID40895073
PMCPMC12393239

What OpenQuestion holds

Textmetadata
LicenceCC BY-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.